• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕米膦酸和唑来膦酸对颌骨药物相关性骨坏死口腔黏膜影响的综述

A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.

作者信息

Bullock George, Miller Cheryl A, McKechnie Alasdair, Hearnden Vanessa

机构信息

Department of Materials Science and Engineering, Kroto Research Institute, The University of Sheffield, Sheffield, United Kingdom.

School of Clinical Dentistry, The University of Sheffield, Sheffield, United Kingdom.

出版信息

Front Oral Health. 2022 Feb 9;2:822411. doi: 10.3389/froh.2021.822411. eCollection 2021.

DOI:10.3389/froh.2021.822411
PMID:35224540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8865370/
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a growing problem without an effective treatment, presenting as necrotic bone sections exposed via lesions in the overlying soft tissue. There is currently a lack of clarity on how the factors involved in MRONJ development and progression contribute to disease prognosis and outcomes. Bisphosphonates (BPs), the most common cause of MRONJ, affect bone remodeling, angiogenesis, infection, inflammation and soft tissue toxicity, all of which contribute to MRONJ development. This article reviews the cellular mechanisms through which BPs contribute to MRONJ pathology, with a focus on the effects on cells of the oral mucosa. BPs have been shown to reduce cell viability, reduce proliferation, and increase apoptosis in oral keratinocytes and fibroblasts. BPs have also been demonstrated to reduce epithelial thickness and prevent epithelial formation in three-dimensional tissue engineered models of the oral mucosa. This combination of factors demonstrates how BPs lead to the reduced wound healing seen in MRONJ and begins to uncover the mechanisms through which these effects occur. The evidence presented here supports identification of targets which can be used to develop novel treatment strategies to promote soft tissue wound healing and restore mucosal coverage of exposed bone in MRONJ.

摘要

药物相关性颌骨坏死(MRONJ)是一个日益严重且缺乏有效治疗方法的问题,表现为坏死骨段通过覆盖其上的软组织病变暴露出来。目前,对于MRONJ发生和发展过程中涉及的因素如何影响疾病预后和结局尚不清楚。双膦酸盐(BP)是MRONJ最常见的病因,它会影响骨重塑、血管生成、感染、炎症和软组织毒性,所有这些都与MRONJ的发生有关。本文综述了BP导致MRONJ病理改变的细胞机制,重点关注其对口腔黏膜细胞的影响。研究表明,BP可降低口腔角质形成细胞和成纤维细胞的细胞活力、减少增殖并增加凋亡。在口腔黏膜的三维组织工程模型中,BP还被证明可减少上皮厚度并阻止上皮形成。这些因素共同表明了BP如何导致MRONJ中伤口愈合能力下降,并开始揭示这些影响发生的机制。本文提供的证据支持确定可用于开发新治疗策略的靶点,以促进软组织伤口愈合并恢复MRONJ中暴露骨的黏膜覆盖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/dacaa944bcf7/froh-02-822411-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/1804619fac40/froh-02-822411-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/772df1756fc3/froh-02-822411-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/aaba95dbf4b8/froh-02-822411-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/dacaa944bcf7/froh-02-822411-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/1804619fac40/froh-02-822411-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/772df1756fc3/froh-02-822411-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/aaba95dbf4b8/froh-02-822411-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ba/8865370/dacaa944bcf7/froh-02-822411-g0004.jpg

相似文献

1
A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.帕米膦酸和唑来膦酸对颌骨药物相关性骨坏死口腔黏膜影响的综述
Front Oral Health. 2022 Feb 9;2:822411. doi: 10.3389/froh.2021.822411. eCollection 2021.
2
Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro.合成羟基磷灰石在体外抑制双膦酸盐对口腔黏膜的毒性。
Materials (Basel). 2020 May 1;13(9):2086. doi: 10.3390/ma13092086.
3
Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.低水平激光疗法通过 IL-1RA 介导的原发性牙龈创面愈合预防药物相关性颌骨样骨坏死性病变。
BMC Oral Health. 2023 Jan 10;23(1):14. doi: 10.1186/s12903-022-02678-1.
4
Effect of Geranylgeraniol (GGOH) on Bisphosphonate-Induced Cytotoxicity of Oral Mucosa Cells.香叶基香叶醇(GGOH)对双膦酸盐诱导的口腔黏膜细胞毒性的影响。
Front Oral Health. 2022 Jun 20;3:892615. doi: 10.3389/froh.2022.892615. eCollection 2022.
5
Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.唑来膦酸治疗小鼠牙槽骨骨坏死中,挽救性双膦酸盐治疗可改善拔牙窝愈合。
Bone. 2019 Jun;123:115-128. doi: 10.1016/j.bone.2019.03.027. Epub 2019 Mar 26.
6
Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: A major adverse effect of bisphosphonate therapy.内皮祖细胞抑制大鼠模型中的下颌骨骨坏死:双膦酸盐治疗的主要不良反应。
Sci Rep. 2019 Dec 11;9(1):18896. doi: 10.1038/s41598-019-55383-5.
7
Combinatorial effects of hydroxyapatite and Tualang honey on medication-related osteonecrosis of the jaw (MRONJ): An in vitro study.羟基磷灰石与土琅蜂蜜对药物性颌骨坏死(MRONJ)的联合作用:一项体外研究。
J Stomatol Oral Maxillofac Surg. 2025 Feb;126(1):101999. doi: 10.1016/j.jormas.2024.101999. Epub 2024 Jul 30.
8
Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.颌骨药物相关性骨坏死的影像学检查方法(2),颌骨药物相关性骨坏死立场文件概述及日本颌骨药物相关性骨坏死的现状
Jpn Dent Sci Rev. 2019 Nov;55(1):71-75. doi: 10.1016/j.jdsr.2018.11.003. Epub 2019 Mar 18.
9
Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.啮齿动物药物相关性颌骨样骨坏死病变:全面的系统评价和荟萃分析。
Gerodontology. 2019 Dec;36(4):313-324. doi: 10.1111/ger.12416. Epub 2019 Aug 2.
10
Alendronate or Zoledronic acid do not impair wound healing after tooth extraction in postmenopausal women with osteoporosis.阿仑膦酸钠或唑来膦酸并不影响绝经后骨质疏松症女性拔牙后伤口愈合。
Bone. 2020 Aug;137:115412. doi: 10.1016/j.bone.2020.115412. Epub 2020 May 20.

引用本文的文献

1
Determinants of outcome in cancer patients with medication-related osteonecrosis of the jaw: A 19-year retrospective study.药物相关性颌骨坏死癌症患者的预后决定因素:一项19年的回顾性研究。
Oral Oncol Rep. 2024 Jun;10. doi: 10.1016/j.oor.2024.100488. Epub 2024 May 6.
2
Antiresorptive agents enhance ossification of free flap reconstructions of the mandible: a radiological retrospective cohort study.抗吸收剂可增强下颌骨游离皮瓣重建的骨化:一项放射学回顾性队列研究。
Front Oncol. 2024 Jun 12;14:1401165. doi: 10.3389/fonc.2024.1401165. eCollection 2024.
3
Medication-related osteonecrosis of the jaw: Case series and literature review.

本文引用的文献

1
Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.药物相关性颌骨坏死的临床注意事项:全面文献回顾。
Int J Implant Dent. 2021 May 14;7(1):47. doi: 10.1186/s40729-021-00323-0.
2
Bisphosphonates and breast cancer - From cautious palliation to saving lives.双膦酸盐类药物与乳腺癌——从谨慎姑息到拯救生命。
Bone. 2020 Nov;140:115570. doi: 10.1016/j.bone.2020.115570. Epub 2020 Jul 31.
3
A Drug Holiday Reduces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model.
药物相关性颌骨坏死:病例系列与文献综述
Clin Case Rep. 2024 Apr 20;12(4):e8788. doi: 10.1002/ccr3.8788. eCollection 2024 Apr.
4
Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.啮齿动物作为研究拔牙相关药物性颌骨坏死的动物模型:结局评估。
Arch Oral Biol. 2024 Mar;159:105875. doi: 10.1016/j.archoralbio.2023.105875. Epub 2023 Dec 26.
5
Effect of Geranylgeraniol (GGOH) on Bisphosphonate-Induced Cytotoxicity of Oral Mucosa Cells.香叶基香叶醇(GGOH)对双膦酸盐诱导的口腔黏膜细胞毒性的影响。
Front Oral Health. 2022 Jun 20;3:892615. doi: 10.3389/froh.2022.892615. eCollection 2022.
药物假期可降低小型猪模型中药物相关性颌骨坏死的发生率和严重程度。
J Bone Miner Res. 2020 Nov;35(11):2179-2192. doi: 10.1002/jbmr.4119. Epub 2020 Aug 10.
4
Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro.合成羟基磷灰石在体外抑制双膦酸盐对口腔黏膜的毒性。
Materials (Basel). 2020 May 1;13(9):2086. doi: 10.3390/ma13092086.
5
Impact of bisphosphonates on the proliferation and gene expression of human fibroblasts.双膦酸盐对人成纤维细胞增殖和基因表达的影响。
Int J Med Sci. 2019 Oct 21;16(12):1534-1540. doi: 10.7150/ijms.36994. eCollection 2019.
6
Gingival fibroblasts and medication-related osteonecrosis of the jaw: Results by real-time and wound healing in vitro assays.牙龈成纤维细胞与药物相关性颌骨坏死:实时和体外伤口愈合试验的结果。
J Craniomaxillofac Surg. 2019 Sep;47(9):1464-1474. doi: 10.1016/j.jcms.2019.06.004. Epub 2019 Jun 8.
7
Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges.欧洲颌骨药物性骨坏死特别工作组研讨会——当前挑战
Oral Dis. 2019 Oct;25(7):1815-1821. doi: 10.1111/odi.13160. Epub 2019 Aug 19.
8
Synthetic Calcium Phosphate Ceramics as a Potential Treatment for Bisphosphonate-Related Osteonecrosis of the Jaw.合成磷酸钙陶瓷作为颌骨双膦酸盐相关骨坏死的一种潜在治疗方法。
Materials (Basel). 2019 Jun 6;12(11):1840. doi: 10.3390/ma12111840.
9
Geranylgeraniol (GGOH) as a Mevalonate Pathway Activator in the Rescue of Bone Cells Treated with Zoledronic Acid: An In Vitro Study.香叶基香叶醇(GGOH)作为甲羟戊酸途径激活剂对唑来膦酸处理的骨细胞的挽救作用:一项体外研究
Stem Cells Int. 2019 Jan 9;2019:4351327. doi: 10.1155/2019/4351327. eCollection 2019.
10
Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway.表皮生长因子通过表皮生长因子受体 (EGFR)/Akt/磷酸肌醇 3-激酶 (PI3K) 信号通路逆转唑来膦酸对人口腔角质形成细胞和人血管内皮细胞的体外抑制作用。
Med Sci Monit. 2019 Jan 24;25:700-710. doi: 10.12659/MSM.911579.